Breaking News Instant updates and real-time market news.

ARGS

Argos Therapeutics

$0.26

0.0127 (5.18%)

17:06
08/09/17
08/09
17:06
08/09/17
17:06

Argos Therapeutics reports Q2 EPS (21c), consensus (26c)

Reports Q2 revenue $69,693, consensus $100,000. "Despite what has clearly been a challenging period, Argos made substantial progress during the most recent quarter," stated Jeff Abbey, CEO of Argos Therapeutics. "First, we were pleased to have a constructive meeting with the FDA, which agreed with our decision to continue the Phase 3 ADAPT trial of Rocapuldencel-T for the treatment of metastatic renal cell carcinoma until we reach 290 events, the pre-specified number of events at which the analysis of overall survival, the primary endpoint, is to be conducted. We are grateful to our investigators and patients for their continued support of our efforts, and we look forward to our next planned analysis at 290 events, which we expect to occur during the first half of 2018."

ARGS Argos Therapeutics
$0.26

0.0127 (5.18%)

02/22/17
NEED
02/22/17
DOWNGRADE
NEED
Hold
Argos Therapeutics downgraded to Hold from Buy at Needham
02/22/17
02/22/17
DOWNGRADE

Market Perform
Argos Therapeutics downgraded to Market Perform from Outperform at FBR Capital
02/22/17
JMPS
02/22/17
DOWNGRADE
JMPS
Market Perform
Argos Therapeutics downgraded to Market Perform at JMP Securities
JMP Securities analyst Michael King downgraded Argos Therapeutics to Market Perform from Outperform after the Independent Data Monitoring Committee for the company's pivotal Phase 3 ADAPT clinical trial of rocapuldencel-T in combination with sunitinib/standard-of-care for the treatment of metastatic renal cell carcinoma recommended the study be discontinued for futility. Stifel also downgraded the shares today.
02/22/17
STFL
02/22/17
DOWNGRADE
STFL
Hold
Argos Therapeutics downgraded to Hold from Buy at Stifel
Stifel downgraded Argos Therapeutics to Hold following the IDMC recommendation to discontinue the ADAPT Phase 3 trial.

TODAY'S FREE FLY STORIES

INVA

Innoviva

$13.06

0.09 (0.69%)

, GSK

GlaxoSmithKline

$35.06

-0.13 (-0.37%)

06:37
11/20/17
11/20
06:37
11/20/17
06:37
Initiation
Innoviva, GlaxoSmithKline initiated  »

Innoviva initiated with a…

INVA

Innoviva

$13.06

0.09 (0.69%)

GSK

GlaxoSmithKline

$35.06

-0.13 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNK

SPDR Barclays High Yield Bond

$36.79

-0.02 (-0.05%)

06:37
11/20/17
11/20
06:37
11/20/17
06:37
Technical Analysis
SPDR Barclays High Yield Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJB

ProShares Short High Yield

$23.25

-0.02 (-0.09%)

06:36
11/20/17
11/20
06:36
11/20/17
06:36
Technical Analysis
ProShares Short High Yield: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVP

Avon Products

$1.94

0.04 (2.11%)

, COTY

Coty

$17.05

0.2 (1.19%)

06:36
11/20/17
11/20
06:36
11/20/17
06:36
Recommendations
Avon Products, Coty analyst commentary  »

Coty may consider…

AVP

Avon Products

$1.94

0.04 (2.11%)

COTY

Coty

$17.05

0.2 (1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

06:36
11/20/17
11/20
06:36
11/20/17
06:36
Downgrade
Ligand rating change  »

Ligand downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HYG

iShares iBoxx $ High Yield Corporate Bond

$87.47

-0.06 (-0.07%)

06:36
11/20/17
11/20
06:36
11/20/17
06:36
Technical Analysis
iShares iBoxx $ High Yield Corporate Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$120.46

0.15 (0.12%)

06:35
11/20/17
11/20
06:35
11/20/17
06:35
Technical Analysis
iShares iBoxx $ Investment Grade Corporate Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLT

iShares 20+ Year Treasury Bond Fund

$126.39

0.93 (0.74%)

06:35
11/20/17
11/20
06:35
11/20/17
06:35
Technical Analysis
iShares 20+ Year Treasury Bond Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$24.99

-0.16 (-0.64%)

, BA

Boeing

$262.26

-1.44 (-0.55%)

06:35
11/20/17
11/20
06:35
11/20/17
06:35
Periodicals
Airbus faces challenges over stalled A380 Emirates deal, Reuters reports »

Airbus (EADSY) is facing…

EADSY

Airbus

$24.99

-0.16 (-0.64%)

BA

Boeing

$262.26

-1.44 (-0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATCEY

Altice

06:34
11/20/17
11/20
06:34
11/20/17
06:34
Hot Stocks
Altice: Majority investor Next does not hold any margin loan exposure to Altice »

Information service…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLV

iShares Silver Trust

$16.31

0.19 (1.18%)

06:34
11/20/17
11/20
06:34
11/20/17
06:34
Technical Analysis
iShares Silver Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USLV

VelocityShares 3x Long Silver ETN

$12.56

0.45 (3.72%)

06:34
11/20/17
11/20
06:34
11/20/17
06:34
Technical Analysis
VelocityShares 3x Long Silver ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATCEY

Altice

06:34
11/20/17
11/20
06:34
11/20/17
06:34
Hot Stocks
Breaking Hot Stocks news story on Altice »

Altice says will not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYR

DJ US Real Estate Index Fund

$82.14

-0.38 (-0.46%)

06:33
11/20/17
11/20
06:33
11/20/17
06:33
Technical Analysis
DJ US Real Estate Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATCEY

Altice

, ATUS

Altice USA

$19.86

-0.38 (-1.88%)

06:33
11/20/17
11/20
06:33
11/20/17
06:33
Periodicals
Altice says not in preparation of cash raising by means of equity issuance »

Altice N.V. (ATCEY)…

ATCEY

Altice

ATUS

Altice USA

$19.86

-0.38 (-1.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATCEY

Altice

06:33
11/20/17
11/20
06:33
11/20/17
06:33
Hot Stocks
Breaking Hot Stocks news story on Altice »

Altice: Management has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBB

iShares Nasdaq Biotechnology Index

$311.21

0.4 (0.13%)

06:33
11/20/17
11/20
06:33
11/20/17
06:33
Technical Analysis
iShares Nasdaq Biotechnology Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYAAY

Ryanair

$118.88

1.45 (1.23%)

06:32
11/20/17
11/20
06:32
11/20/17
06:32
Initiation
Ryanair initiated  »

Ryanair initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LABD

Daily S&P Biotech Bear 3x Shares

$5.40

0.01 (0.19%)

06:32
11/20/17
11/20
06:32
11/20/17
06:32
Technical Analysis
Daily S&P Biotech Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWH

MSCI Hong Kong Index

$25.43

-0.17 (-0.66%)

06:32
11/20/17
11/20
06:32
11/20/17
06:32
Technical Analysis
MSCI Hong Kong Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWG

iShares MSCI Germany

$32.71

-0.16 (-0.49%)

06:32
11/20/17
11/20
06:32
11/20/17
06:32
Technical Analysis
iShares MSCI Germany: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IJR

iShares Core S&P Small Cap ETF

$74.63

0.32 (0.43%)

06:31
11/20/17
11/20
06:31
11/20/17
06:31
Technical Analysis
iShares Core S&P Small Cap ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEM

MSCI Emerging Markets Index

$46.82

0.23 (0.49%)

06:31
11/20/17
11/20
06:31
11/20/17
06:31
Technical Analysis
MSCI Emerging Markets Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWW

iShares MSCI Mexico

$50.26

0.48 (0.96%)

06:30
11/20/17
11/20
06:30
11/20/17
06:30
Technical Analysis
iShares MSCI Mexico: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UUP

PowerShares DB US Dollar Index Up

$24.34

-0.07 (-0.29%)

06:30
11/20/17
11/20
06:30
11/20/17
06:30
Technical Analysis
PowerShares DB US Dollar Index Up: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.